

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.83958198 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.83958198 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36454907 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.14704437 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.14704437 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00295880 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 3.90957659 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 3.85421090 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 3.85421090 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.85421090 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.85421090 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.85421090 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 3.85421090 |
| 14 | germinal center formation (GO:0002467) | 3.79356675 |
| 15 | defense response to protozoan (GO:0042832) | 3.54586621 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.47317241 |
| 17 | response to type I interferon (GO:0034340) | 3.46616826 |
| 18 | type I interferon signaling pathway (GO:0060337) | 3.39783754 |
| 19 | cellular response to type I interferon (GO:0071357) | 3.39783754 |
| 20 | response to protozoan (GO:0001562) | 3.37559251 |
| 21 | * detection of other organism (GO:0098543) | 3.20779513 |
| 22 | * regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18457690 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 3.16739111 |
| 24 | positive regulation of type 2 immune response (GO:0002830) | 3.14875345 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 3.11587825 |
| 26 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.09585547 |
| 27 | low-density lipoprotein particle clearance (GO:0034383) | 3.07429527 |
| 28 | myeloid dendritic cell differentiation (GO:0043011) | 3.03141218 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.03018307 |
| 30 | NIK/NF-kappaB signaling (GO:0038061) | 3.00158552 |
| 31 | mature B cell differentiation involved in immune response (GO:0002313) | 3.00076427 |
| 32 | * detection of bacterium (GO:0016045) | 2.99755014 |
| 33 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.99442823 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.98496057 |
| 35 | negative regulation of innate immune response (GO:0045824) | 2.98013650 |
| 36 | * regulation of antigen processing and presentation (GO:0002577) | 2.96052862 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 2.95036831 |
| 38 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.93415484 |
| 39 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91934424 |
| 40 | neutrophil activation involved in immune response (GO:0002283) | 2.91392767 |
| 41 | T cell migration (GO:0072678) | 2.90729174 |
| 42 | B cell mediated immunity (GO:0019724) | 2.90582176 |
| 43 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.89524603 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 2.87399081 |
| 45 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.86376047 |
| 46 | myeloid dendritic cell activation (GO:0001773) | 2.85449439 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 2.84154704 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.83795349 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.81700380 |
| 50 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.80934193 |
| 51 | B cell receptor signaling pathway (GO:0050853) | 2.79124328 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.75920008 |
| 53 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.75821300 |
| 54 | regulation of type 2 immune response (GO:0002828) | 2.75249241 |
| 55 | sphingosine metabolic process (GO:0006670) | 2.74393856 |
| 56 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73144676 |
| 57 | positive regulation of interferon-beta production (GO:0032728) | 2.71953968 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 2.70608469 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.69890949 |
| 60 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.69459554 |
| 61 | response to host immune response (GO:0052572) | 2.69104229 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69104229 |
| 63 | positive regulation of humoral immune response (GO:0002922) | 2.68775807 |
| 64 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.67046035 |
| 65 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.66411399 |
| 66 | regulation of chronic inflammatory response (GO:0002676) | 2.65709997 |
| 67 | regulation of tolerance induction (GO:0002643) | 2.65306164 |
| 68 | regulation of T-helper cell differentiation (GO:0045622) | 2.65278758 |
| 69 | regulation of interleukin-12 production (GO:0032655) | 2.64799075 |
| 70 | negative regulation of viral genome replication (GO:0045071) | 2.64526003 |
| 71 | response to peptidoglycan (GO:0032494) | 2.64026830 |
| 72 | leukocyte aggregation (GO:0070486) | 2.63880502 |
| 73 | cellular response to interferon-gamma (GO:0071346) | 2.63244690 |
| 74 | regulation of necroptotic process (GO:0060544) | 2.62668902 |
| 75 | detection of molecule of bacterial origin (GO:0032490) | 2.61592970 |
| 76 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.60725702 |
| 77 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.60121526 |
| 78 | negative regulation of granulocyte differentiation (GO:0030853) | 2.58411085 |
| 79 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.58140336 |
| 80 | interferon-gamma secretion (GO:0072643) | 2.57880335 |
| 81 | regulation of cholesterol storage (GO:0010885) | 2.56939546 |
| 82 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.56802770 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 2.56192650 |
| 84 | apoptotic cell clearance (GO:0043277) | 2.55215486 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.54420205 |
| 86 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.54420205 |
| 87 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.54008785 |
| 88 | T-helper cell differentiation (GO:0042093) | 2.54008785 |
| 89 | cellular response to exogenous dsRNA (GO:0071360) | 2.53968070 |
| 90 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.53384715 |
| 91 | negative regulation of interleukin-6 production (GO:0032715) | 2.52323135 |
| 92 | T-helper 1 type immune response (GO:0042088) | 2.51074926 |
| 93 | response to interferon-alpha (GO:0035455) | 2.48102765 |
| 94 | establishment of endothelial barrier (GO:0061028) | 2.46358776 |
| 95 | positive thymic T cell selection (GO:0045059) | 2.43533991 |
| 96 | response to host (GO:0075136) | 2.42922919 |
| 97 | response to host defenses (GO:0052200) | 2.42922919 |
| 98 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.42922919 |
| 99 | response to muramyl dipeptide (GO:0032495) | 2.42419828 |
| 100 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.42123557 |
| 101 | virion attachment to host cell (GO:0019062) | 2.42058559 |
| 102 | adhesion of symbiont to host cell (GO:0044650) | 2.42058559 |
| 103 | mannose metabolic process (GO:0006013) | 2.41914342 |
| 104 | respiratory burst (GO:0045730) | 2.41690487 |
| 105 | cellular extravasation (GO:0045123) | 2.41059185 |
| 106 | adhesion of symbiont to host (GO:0044406) | 2.39096186 |
| 107 | positive regulation of p38MAPK cascade (GO:1900745) | 2.38620750 |
| 108 | growth hormone receptor signaling pathway (GO:0060396) | 2.38254072 |
| 109 | diol metabolic process (GO:0034311) | 2.37802110 |
| 110 | neutrophil activation (GO:0042119) | 2.37173250 |
| 111 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.35938639 |
| 112 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.34837715 |
| 113 | membrane raft organization (GO:0031579) | 2.34247712 |
| 114 | leukocyte tethering or rolling (GO:0050901) | 2.33201369 |
| 115 | leukocyte cell-cell adhesion (GO:0007159) | 2.32715547 |
| 116 | granulocyte activation (GO:0036230) | 2.31410476 |
| 117 | macrophage activation (GO:0042116) | 2.29709401 |
| 118 | response to laminar fluid shear stress (GO:0034616) | 2.29216427 |
| 119 | positive regulation of histone deacetylation (GO:0031065) | 2.28877306 |
| 120 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.28794369 |
| 121 | sphingomyelin metabolic process (GO:0006684) | 2.28364470 |
| 122 | surfactant homeostasis (GO:0043129) | 2.28349826 |
| 123 | regulation of monocyte chemotaxis (GO:0090025) | 2.26304366 |
| 124 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.24271595 |
| 125 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.24069374 |
| 126 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.22837786 |
| 127 | negative regulation of lipid storage (GO:0010888) | 2.21744159 |
| 128 | myeloid cell activation involved in immune response (GO:0002275) | 2.21706218 |
| 129 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.20505862 |
| 130 | * detection of external biotic stimulus (GO:0098581) | 2.18450980 |
| 131 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.17839268 |
| 132 | negative regulation of interleukin-12 production (GO:0032695) | 2.17616924 |
| 133 | heterotypic cell-cell adhesion (GO:0034113) | 2.16712470 |
| 134 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.16318382 |
| 135 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.15494641 |
| 136 | amyloid precursor protein catabolic process (GO:0042987) | 2.14689923 |
| 137 | valine metabolic process (GO:0006573) | 2.14554430 |
| 138 | * positive regulation of antigen processing and presentation (GO:0002579) | 2.13875998 |
| 139 | plasma lipoprotein particle clearance (GO:0034381) | 2.13417875 |
| 140 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.12274139 |
| 141 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.11321886 |
| 142 | regulation of cellular extravasation (GO:0002691) | 2.10341721 |
| 143 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.09997947 |
| 144 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.09404138 |
| 145 | complement activation, alternative pathway (GO:0006957) | 2.09163695 |
| 146 | cellular response to interferon-beta (GO:0035458) | 2.09092483 |
| 147 | response to interferon-beta (GO:0035456) | 2.08862191 |
| 148 | sphingoid metabolic process (GO:0046519) | 2.08646336 |
| 149 | pinocytosis (GO:0006907) | 2.08606208 |
| 150 | response to lipoprotein particle (GO:0055094) | 2.06255013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.76726808 |
| 2 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.91215029 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.72511198 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.69423415 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.66391471 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.14047928 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.76319541 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.72740975 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.66012909 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61935036 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61168322 |
| 12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.44441479 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44166385 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.31906336 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.30305539 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27663906 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.24178440 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19236761 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17460202 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.15052492 |
| 21 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.13658703 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13197329 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11347630 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.07986992 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.06775662 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.04014250 |
| 27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94032167 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89452737 |
| 29 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86281240 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76431886 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72183031 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70441318 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68328021 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.65779703 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64904038 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.61297990 |
| 37 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56683478 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54952991 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.52550315 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.50870741 |
| 41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50573986 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45604007 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44555636 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42792859 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42509199 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42381293 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40333222 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39933935 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38775373 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37588726 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37124300 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.35284218 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35212555 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35117088 |
| 55 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34017252 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.32609837 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31426591 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26832622 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26182801 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26126222 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25683693 |
| 62 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24169439 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24073124 |
| 64 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23226665 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23011194 |
| 66 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22797390 |
| 67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.20118611 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19267425 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18173679 |
| 70 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17889983 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16357760 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15076777 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 1.15059676 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14582333 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14122249 |
| 76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13371584 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12127239 |
| 78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11388359 |
| 79 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10784841 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09434508 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09050269 |
| 82 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09036381 |
| 83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08884713 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07662098 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07417493 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07296056 |
| 87 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07199363 |
| 88 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07184253 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06555764 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06536068 |
| 91 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06111854 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05757614 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04602378 |
| 94 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.04489468 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04295360 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03256980 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03163542 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02235876 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02235876 |
| 100 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02211380 |
| 101 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.01701423 |
| 102 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00940391 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00633474 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99208892 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98899487 |
| 106 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97332884 |
| 107 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96991272 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.96467062 |
| 109 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95638274 |
| 110 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95120692 |
| 111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94376236 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94330317 |
| 113 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94106574 |
| 114 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93144047 |
| 115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93027353 |
| 116 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92564125 |
| 117 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91570740 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91359446 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91215765 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91063682 |
| 121 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89945237 |
| 122 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89760779 |
| 123 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89760779 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89563238 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89504059 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89499218 |
| 127 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89449450 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88244047 |
| 129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87702903 |
| 130 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87671489 |
| 131 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86871817 |
| 132 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.84507687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.53688850 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 3.24702529 |
| 3 | MP0009278_abnormal_bone_marrow | 3.08998376 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.46566614 |
| 5 | MP0009785_altered_susceptibility_to | 2.46023844 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.37894710 |
| 7 | MP0005451_abnormal_body_composition | 2.31171293 |
| 8 | * MP0005387_immune_system_phenotype | 2.24014953 |
| 9 | * MP0001790_abnormal_immune_system | 2.24014953 |
| 10 | MP0003436_decreased_susceptibility_to | 2.23302922 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.17435593 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.17406663 |
| 13 | * MP0005025_abnormal_response_to | 2.12012336 |
| 14 | MP0000685_abnormal_immune_system | 2.10124687 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.09885817 |
| 16 | * MP0002419_abnormal_innate_immunity | 2.06365004 |
| 17 | MP0005671_abnormal_response_to | 1.99939119 |
| 18 | MP0003303_peritoneal_inflammation | 1.99736593 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.93913777 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.85115418 |
| 21 | MP0001800_abnormal_humoral_immune | 1.79172183 |
| 22 | MP0006082_CNS_inflammation | 1.78001046 |
| 23 | MP0004947_skin_inflammation | 1.74954368 |
| 24 | MP0009840_abnormal_foam_cell | 1.74256008 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 1.73517071 |
| 26 | MP0003828_pulmonary_edema | 1.73052263 |
| 27 | * MP0002452_abnormal_antigen_presenting | 1.70500508 |
| 28 | * MP0002723_abnormal_immune_serum | 1.68276398 |
| 29 | MP0004510_myositis | 1.67743637 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.64302780 |
| 31 | MP0008004_abnormal_stomach_pH | 1.56940047 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.54057421 |
| 33 | MP0001873_stomach_inflammation | 1.51644373 |
| 34 | MP0001879_abnormal_lymphatic_vessel | 1.49935957 |
| 35 | * MP0001819_abnormal_immune_cell | 1.49107297 |
| 36 | * MP0002420_abnormal_adaptive_immunity | 1.48796687 |
| 37 | MP0001851_eye_inflammation | 1.46382520 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.42431697 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.42288650 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.38538077 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.38538077 |
| 42 | MP0000343_altered_response_to | 1.37361989 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.35539632 |
| 44 | MP0005670_abnormal_white_adipose | 1.35177992 |
| 45 | MP0003091_abnormal_cell_migration | 1.34593058 |
| 46 | MP0001853_heart_inflammation | 1.34504073 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.33239735 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.33038037 |
| 49 | MP0009764_decreased_sensitivity_to | 1.32273927 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.31636803 |
| 51 | MP0008469_abnormal_protein_level | 1.31599700 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.31311276 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.28579565 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.26843400 |
| 55 | MP0003690_abnormal_glial_cell | 1.24456947 |
| 56 | MP0002722_abnormal_immune_system | 1.24452302 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.23943485 |
| 58 | MP0005310_abnormal_salivary_gland | 1.23011730 |
| 59 | MP0004272_abnormal_basement_membrane | 1.19654213 |
| 60 | MP0005365_abnormal_bile_salt | 1.19646600 |
| 61 | MP0003448_altered_tumor_morphology | 1.18656455 |
| 62 | MP0004147_increased_porphyrin_level | 1.18631478 |
| 63 | MP0002405_respiratory_system_inflammati | 1.18033666 |
| 64 | MP0002796_impaired_skin_barrier | 1.15453840 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.15410962 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.14705244 |
| 67 | MP0003195_calcinosis | 1.14300961 |
| 68 | MP0002933_joint_inflammation | 1.13353211 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 1.10825207 |
| 70 | MP0000920_abnormal_myelination | 1.08554878 |
| 71 | MP0004130_abnormal_muscle_cell | 1.08539745 |
| 72 | MP0002006_tumorigenesis | 1.07978099 |
| 73 | MP0009763_increased_sensitivity_to | 1.07746532 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.05729038 |
| 75 | MP0000249_abnormal_blood_vessel | 1.05213252 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 1.04967279 |
| 77 | MP0000716_abnormal_immune_system | 1.04785770 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 1.04533779 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.04150831 |
| 80 | MP0005275_abnormal_skin_tensile | 1.04083738 |
| 81 | MP0003763_abnormal_thymus_physiology | 1.03025001 |
| 82 | MP0008260_abnormal_autophagy | 1.00407302 |
| 83 | MP0000609_abnormal_liver_physiology | 1.00107694 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.98779392 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.98072191 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.97633501 |
| 87 | MP0001958_emphysema | 0.96782620 |
| 88 | MP0003045_fibrosis | 0.96328174 |
| 89 | MP0005390_skeleton_phenotype | 0.94948727 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.94240253 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.94176493 |
| 92 | MP0002139_abnormal_hepatobiliary_system | 0.93895336 |
| 93 | MP0005166_decreased_susceptibility_to | 0.91774235 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.90928555 |
| 95 | MP0005085_abnormal_gallbladder_physiolo | 0.90869944 |
| 96 | MP0004883_abnormal_blood_vessel | 0.90491303 |
| 97 | MP0002118_abnormal_lipid_homeostasis | 0.89570192 |
| 98 | MP0003279_aneurysm | 0.89103480 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.86502474 |
| 100 | MP0005164_abnormal_response_to | 0.86322420 |
| 101 | MP0005023_abnormal_wound_healing | 0.85080719 |
| 102 | MP0002398_abnormal_bone_marrow | 0.84772068 |
| 103 | MP0010329_abnormal_lipoprotein_level | 0.84644280 |
| 104 | MP0003866_abnormal_defecation | 0.83986950 |
| 105 | MP0005165_increased_susceptibility_to | 0.83873821 |
| 106 | MP0004381_abnormal_hair_follicle | 0.82448563 |
| 107 | MP0002396_abnormal_hematopoietic_system | 0.81923378 |
| 108 | MP0002009_preneoplasia | 0.81884879 |
| 109 | MP0003075_altered_response_to | 0.80942904 |
| 110 | MP0003172_abnormal_lysosome_physiology | 0.80838550 |
| 111 | MP0000858_altered_metastatic_potential | 0.80498617 |
| 112 | MP0002254_reproductive_system_inflammat | 0.80494358 |
| 113 | MP0006054_spinal_hemorrhage | 0.80093000 |
| 114 | MP0000465_gastrointestinal_hemorrhage | 0.79617893 |
| 115 | MP0002429_abnormal_blood_cell | 0.79075176 |
| 116 | MP0005360_urolithiasis | 0.78973179 |
| 117 | MP0001663_abnormal_digestive_system | 0.78659136 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.77150542 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.77142611 |
| 120 | MP0000604_amyloidosis | 0.76241825 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.73584035 |
| 122 | MP0002132_abnormal_respiratory_system | 0.73054203 |
| 123 | MP0010307_abnormal_tumor_latency | 0.67192309 |
| 124 | MP0009115_abnormal_fat_cell | 0.65877729 |
| 125 | MP0003806_abnormal_nucleotide_metabolis | 0.65851786 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.65163006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.38224754 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.18416716 |
| 3 | Spontaneous hematomas (HP:0007420) | 3.94416447 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.80673337 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.80673337 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.80673337 |
| 7 | Hematochezia (HP:0002573) | 3.72403813 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.50456136 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.45991255 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36165721 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.34300519 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.32105047 |
| 13 | Axonal loss (HP:0003447) | 3.32071332 |
| 14 | Chronic otitis media (HP:0000389) | 3.26659604 |
| 15 | Keratoconjunctivitis sicca (HP:0001097) | 3.18780168 |
| 16 | Thick nail (HP:0001805) | 3.18252309 |
| 17 | Abnormality of the nasal mucosa (HP:0000433) | 3.17491577 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.16329497 |
| 19 | T lymphocytopenia (HP:0005403) | 3.13430105 |
| 20 | Increased IgE level (HP:0003212) | 3.12995754 |
| 21 | Meningitis (HP:0001287) | 3.11893837 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.10897579 |
| 23 | Hypoglycemic seizures (HP:0002173) | 3.00064951 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 2.95880267 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92526910 |
| 26 | Keratoconjunctivitis (HP:0001096) | 2.87706216 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83959473 |
| 28 | Obstructive lung disease (HP:0006536) | 2.83959473 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 2.80197791 |
| 30 | Myositis (HP:0100614) | 2.79473366 |
| 31 | Abnormality of B cell number (HP:0010975) | 2.77548344 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 2.74731269 |
| 33 | Colitis (HP:0002583) | 2.70746562 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.69428426 |
| 35 | Nonimmune hydrops fetalis (HP:0001790) | 2.68450026 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 2.66817458 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.63688324 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.63688324 |
| 39 | B lymphocytopenia (HP:0010976) | 2.62214898 |
| 40 | Pustule (HP:0200039) | 2.60210057 |
| 41 | Granulocytopenia (HP:0001913) | 2.59529409 |
| 42 | Increased IgM level (HP:0003496) | 2.58618994 |
| 43 | Hemorrhage of the eye (HP:0011885) | 2.55604485 |
| 44 | Stomatitis (HP:0010280) | 2.54607615 |
| 45 | Leukocytosis (HP:0001974) | 2.54533952 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.54175617 |
| 47 | Joint hemorrhage (HP:0005261) | 2.53905361 |
| 48 | Myocardial infarction (HP:0001658) | 2.53355241 |
| 49 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.52938860 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.52221401 |
| 51 | Nasal polyposis (HP:0100582) | 2.51674039 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.50057444 |
| 53 | Encephalitis (HP:0002383) | 2.49530663 |
| 54 | Prolonged bleeding time (HP:0003010) | 2.45748327 |
| 55 | Arterial thrombosis (HP:0004420) | 2.45350367 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.45055339 |
| 57 | Esophageal varix (HP:0002040) | 2.44855842 |
| 58 | Complement deficiency (HP:0004431) | 2.44368208 |
| 59 | Orchitis (HP:0100796) | 2.43922214 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43460827 |
| 61 | Glomerulonephritis (HP:0000099) | 2.38482288 |
| 62 | Symptomatic seizures (HP:0011145) | 2.38129123 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.37343493 |
| 64 | Abnormality of the intrinsic pathway (HP:0010989) | 2.36915942 |
| 65 | Chest pain (HP:0100749) | 2.35923244 |
| 66 | Recurrent skin infections (HP:0001581) | 2.33674707 |
| 67 | Agammaglobulinemia (HP:0004432) | 2.33160219 |
| 68 | Gastrointestinal stroma tumor (HP:0100723) | 2.32892480 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.31759275 |
| 70 | Increased cerebral lipofuscin (HP:0011813) | 2.31191087 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.31152932 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31152932 |
| 73 | Nephritis (HP:0000123) | 2.29687429 |
| 74 | Polycythemia (HP:0001901) | 2.28946138 |
| 75 | Eosinophilia (HP:0001880) | 2.28921925 |
| 76 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.27574621 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.26543230 |
| 78 | Periodontitis (HP:0000704) | 2.26288629 |
| 79 | Gingivitis (HP:0000230) | 2.25476747 |
| 80 | Abnormality of complement system (HP:0005339) | 2.24652233 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19485210 |
| 82 | Abnormality of T cells (HP:0002843) | 2.19344872 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18344860 |
| 84 | Osteolytic defects of the hand bones (HP:0009699) | 2.18344860 |
| 85 | Amyloidosis (HP:0011034) | 2.18321587 |
| 86 | Mitral stenosis (HP:0001718) | 2.16015262 |
| 87 | Recurrent bronchitis (HP:0002837) | 2.15222160 |
| 88 | Gangrene (HP:0100758) | 2.14923283 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.13468900 |
| 90 | Xanthomatosis (HP:0000991) | 2.13343092 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13144542 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13144542 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13144542 |
| 94 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.12739671 |
| 95 | Facial diplegia (HP:0001349) | 2.11566553 |
| 96 | Vasculitis (HP:0002633) | 2.10636221 |
| 97 | Urticaria (HP:0001025) | 2.10581924 |
| 98 | Deep venous thrombosis (HP:0002625) | 2.09208764 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 2.08860199 |
| 100 | Abnormality of the pleura (HP:0002103) | 2.06652128 |
| 101 | Pulmonary embolism (HP:0002204) | 2.06494297 |
| 102 | Recurrent viral infections (HP:0004429) | 2.05787598 |
| 103 | Peritonitis (HP:0002586) | 2.04855103 |
| 104 | Asymmetric septal hypertrophy (HP:0001670) | 2.03686446 |
| 105 | Vertigo (HP:0002321) | 2.02991220 |
| 106 | IgA deficiency (HP:0002720) | 2.02198032 |
| 107 | Abnormality of the endocardium (HP:0004306) | 2.02121731 |
| 108 | Emphysema (HP:0002097) | 2.01833118 |
| 109 | Spondylolisthesis (HP:0003302) | 2.01691117 |
| 110 | Restrictive lung disease (HP:0002091) | 2.00635737 |
| 111 | Recurrent fungal infections (HP:0002841) | 2.00614929 |
| 112 | Hyporeflexia of lower limbs (HP:0002600) | 2.00502474 |
| 113 | Petechiae (HP:0000967) | 1.99511862 |
| 114 | Severe combined immunodeficiency (HP:0004430) | 1.97760345 |
| 115 | Ileus (HP:0002595) | 1.97596774 |
| 116 | Anorexia (HP:0002039) | 1.96087411 |
| 117 | Viral hepatitis (HP:0006562) | 1.95884393 |
| 118 | Muscle fiber splitting (HP:0003555) | 1.95853345 |
| 119 | Loss of speech (HP:0002371) | 1.95723289 |
| 120 | Polyneuropathy (HP:0001271) | 1.95633284 |
| 121 | Increased serum ferritin (HP:0003281) | 1.94683127 |
| 122 | Hemoptysis (HP:0002105) | 1.94129920 |
| 123 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.94020238 |
| 124 | Sepsis (HP:0100806) | 1.93988340 |
| 125 | Abnormality of the fingertips (HP:0001211) | 1.93362898 |
| 126 | Polygenic inheritance (HP:0010982) | 1.93207644 |
| 127 | Ketoacidosis (HP:0001993) | 1.91352665 |
| 128 | Combined immunodeficiency (HP:0005387) | 1.91066241 |
| 129 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.90799297 |
| 130 | Gingival bleeding (HP:0000225) | 1.89927479 |
| 131 | Increased CSF protein (HP:0002922) | 1.89285532 |
| 132 | Ventricular tachycardia (HP:0004756) | 1.88688661 |
| 133 | Hyperglycemia (HP:0003074) | 1.85129227 |
| 134 | Anhidrosis (HP:0000970) | 1.84755943 |
| 135 | Insulin resistance (HP:0000855) | 1.84426323 |
| 136 | Increased connective tissue (HP:0009025) | 1.83389181 |
| 137 | Cellulitis (HP:0100658) | 1.83205769 |
| 138 | Generalized aminoaciduria (HP:0002909) | 1.82456806 |
| 139 | Acanthosis nigricans (HP:0000956) | 1.81644254 |
| 140 | Optic neuritis (HP:0100653) | 1.81391914 |
| 141 | Retrobulbar optic neuritis (HP:0100654) | 1.81391914 |
| 142 | Stroke (HP:0001297) | 1.79988477 |
| 143 | Epistaxis (HP:0000421) | 1.78233141 |
| 144 | Purpura (HP:0000979) | 1.76758494 |
| 145 | Cerebral hemorrhage (HP:0001342) | 1.76182118 |
| 146 | Conjunctival telangiectasia (HP:0000524) | 1.75734761 |
| 147 | Osteomyelitis (HP:0002754) | 1.75293319 |
| 148 | Intrahepatic cholestasis (HP:0001406) | 1.73255625 |
| 149 | Hepatosplenomegaly (HP:0001433) | 1.71958006 |
| 150 | Abnormality of T cell number (HP:0011839) | 1.71640958 |
| 151 | Hyperlipoproteinemia (HP:0010980) | 1.71462841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.40328848 |
| 2 | TYK2 | 3.00635170 |
| 3 | ERN1 | 2.89678768 |
| 4 | TIE1 | 2.89563806 |
| 5 | EPHB1 | 2.86010909 |
| 6 | MAP4K1 | 2.70235029 |
| 7 | MAP3K14 | 2.66309105 |
| 8 | PRPF4B | 2.59351458 |
| 9 | JAK1 | 2.29508802 |
| 10 | IRAK3 | 2.27760347 |
| 11 | KDR | 2.27350904 |
| 12 | TBK1 | 2.21621315 |
| 13 | NLK | 2.17442579 |
| 14 | FGFR4 | 2.17168866 |
| 15 | JAK3 | 2.10242588 |
| 16 | TGFBR2 | 2.10072794 |
| 17 | CSK | 2.08711586 |
| 18 | IKBKE | 2.06042306 |
| 19 | BLK | 1.96329071 |
| 20 | TTN | 1.91937539 |
| 21 | IRAK4 | 1.90458796 |
| 22 | ITK | 1.54520448 |
| 23 | ZAP70 | 1.45628484 |
| 24 | MAP3K13 | 1.41535419 |
| 25 | IKBKB | 1.41129289 |
| 26 | KIT | 1.37891080 |
| 27 | TAOK2 | 1.37308405 |
| 28 | TXK | 1.30329103 |
| 29 | CDC42BPA | 1.30059521 |
| 30 | EPHA3 | 1.28164455 |
| 31 | RIPK1 | 1.27556577 |
| 32 | MATK | 1.26689978 |
| 33 | STK10 | 1.26379738 |
| 34 | TNK2 | 1.24786092 |
| 35 | GRK1 | 1.19067518 |
| 36 | GRK6 | 1.18866662 |
| 37 | TESK2 | 1.18616481 |
| 38 | TRIB3 | 1.17441105 |
| 39 | MAP3K11 | 1.17127235 |
| 40 | TRPM7 | 1.16819027 |
| 41 | PTK6 | 1.16572087 |
| 42 | PKN1 | 1.13845278 |
| 43 | SIK1 | 1.12744327 |
| 44 | JAK2 | 1.11640602 |
| 45 | CAMK1D | 1.09402693 |
| 46 | NME2 | 1.06285799 |
| 47 | MOS | 1.04638120 |
| 48 | MET | 1.04382371 |
| 49 | TAOK3 | 1.03500402 |
| 50 | MAPK15 | 1.00008461 |
| 51 | TEC | 0.99849624 |
| 52 | FGFR3 | 0.99190771 |
| 53 | PRKCH | 0.97952979 |
| 54 | BMPR2 | 0.93665172 |
| 55 | MST1R | 0.92525185 |
| 56 | LCK | 0.86967409 |
| 57 | HCK | 0.86573002 |
| 58 | LRRK2 | 0.84064851 |
| 59 | MARK3 | 0.83549188 |
| 60 | BTK | 0.82879573 |
| 61 | IRAK1 | 0.81651116 |
| 62 | FLT3 | 0.81468776 |
| 63 | TAOK1 | 0.79622369 |
| 64 | CHUK | 0.79577296 |
| 65 | MST4 | 0.78969407 |
| 66 | MAP2K3 | 0.77857459 |
| 67 | MYLK | 0.77407600 |
| 68 | CDK6 | 0.75378939 |
| 69 | MAP3K6 | 0.73711502 |
| 70 | MAPK7 | 0.71962269 |
| 71 | STK39 | 0.71118909 |
| 72 | CDK12 | 0.70442683 |
| 73 | RPS6KC1 | 0.70202851 |
| 74 | RPS6KL1 | 0.70202851 |
| 75 | CDK4 | 0.68784130 |
| 76 | DDR2 | 0.67577619 |
| 77 | MAP2K2 | 0.66933231 |
| 78 | PRKG2 | 0.66588504 |
| 79 | PIK3CG | 0.66256823 |
| 80 | BCKDK | 0.66089143 |
| 81 | FRK | 0.65108795 |
| 82 | PIM1 | 0.63912445 |
| 83 | SYK | 0.63316929 |
| 84 | CSF1R | 0.63299009 |
| 85 | MAPK11 | 0.63012894 |
| 86 | PRKCQ | 0.60671143 |
| 87 | HIPK2 | 0.60458162 |
| 88 | RPS6KA6 | 0.57951608 |
| 89 | PRKD1 | 0.57907938 |
| 90 | CAMK1G | 0.57597921 |
| 91 | FES | 0.57516875 |
| 92 | PDK1 | 0.56969120 |
| 93 | MAP3K1 | 0.56818492 |
| 94 | BMX | 0.56744283 |
| 95 | PIM2 | 0.55946960 |
| 96 | GSK3A | 0.55209809 |
| 97 | IGF1R | 0.55078065 |
| 98 | PTK2 | 0.53487865 |
| 99 | GRK7 | 0.52805516 |
| 100 | PRKAA2 | 0.52407964 |
| 101 | LYN | 0.52236039 |
| 102 | RIPK4 | 0.51076255 |
| 103 | SIK3 | 0.50826421 |
| 104 | SMG1 | 0.50789228 |
| 105 | PDGFRA | 0.50733547 |
| 106 | MAP3K3 | 0.50545630 |
| 107 | MAP3K5 | 0.50509534 |
| 108 | MELK | 0.49736988 |
| 109 | DMPK | 0.48154549 |
| 110 | ABL1 | 0.47768569 |
| 111 | NEK9 | 0.47294950 |
| 112 | ICK | 0.47218481 |
| 113 | MAP3K7 | 0.47079852 |
| 114 | MARK2 | 0.46991157 |
| 115 | PDGFRB | 0.46934770 |
| 116 | STK24 | 0.46734804 |
| 117 | CLK1 | 0.45914396 |
| 118 | RPS6KA2 | 0.44815138 |
| 119 | WNK4 | 0.43710544 |
| 120 | PDPK1 | 0.42668759 |
| 121 | FGR | 0.42549902 |
| 122 | MAPK4 | 0.41742318 |
| 123 | MAP2K6 | 0.41593564 |
| 124 | INSR | 0.41344589 |
| 125 | EGFR | 0.40525856 |
| 126 | TGFBR1 | 0.40119013 |
| 127 | RET | 0.40075779 |
| 128 | IRAK2 | 0.38383122 |
| 129 | MAPK12 | 0.36742715 |
| 130 | PRKD2 | 0.36316205 |
| 131 | WNK1 | 0.34179917 |
| 132 | PKN2 | 0.33966454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.32616081 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15967195 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.13679366 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.04616839 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91138248 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.88988274 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82073933 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68586259 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65042229 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.64915263 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.56707927 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.54575013 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.54434640 |
| 14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.49392856 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48245796 |
| 16 | * Pertussis_Homo sapiens_hsa05133 | 1.46449085 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44364086 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43901100 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41201120 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38471966 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35116556 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33469331 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33188934 |
| 24 | ABC transporters_Homo sapiens_hsa02010 | 1.32894251 |
| 25 | Hepatitis C_Homo sapiens_hsa05160 | 1.29549908 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.29170124 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.28547609 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28345001 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.24884809 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.23759769 |
| 31 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20153315 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19926165 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19653466 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18195845 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17739568 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.17273483 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16002912 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15574532 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13877663 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12894264 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11986207 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11647274 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.10496429 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08705766 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08671389 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08590564 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06204645 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 1.05039931 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04005299 |
| 50 | Insulin resistance_Homo sapiens_hsa04931 | 1.03636325 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.03316780 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 1.03056365 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98079334 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95601796 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93881595 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92889647 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89219493 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.88174461 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87295113 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86157888 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84510293 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.82837571 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82474453 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81747322 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.78914180 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78006678 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77364693 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.76099253 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75400590 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74844651 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.73912167 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.72950876 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71076843 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69719362 |
| 75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69344320 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68800722 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68001981 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66840250 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66015143 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.63754428 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62068740 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58795683 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57908890 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57842463 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57451281 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57168246 |
| 87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56372758 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.55524575 |
| 89 | * Shigellosis_Homo sapiens_hsa05131 | 0.55438351 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54935604 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53321538 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52472841 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51932744 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.51671091 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50543127 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50123243 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50070452 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49043070 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48622667 |
| 100 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47631524 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47057226 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46086036 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.45434019 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44761966 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44438915 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.44024068 |
| 107 | Adherens junction_Homo sapiens_hsa04520 | 0.43154342 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42887106 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42318706 |
| 110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42139958 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41810887 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41377165 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41233393 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40877820 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40509251 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39429706 |
| 117 | Asthma_Homo sapiens_hsa05310 | 0.38241747 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34614560 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33412951 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.31249463 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29436261 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27648710 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27266345 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26584353 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26261884 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26167102 |
| 127 | Thyroid cancer_Homo sapiens_hsa05216 | 0.25951361 |

